| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-03-31 10:34 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,638
+1,012 vol $11.50 each |
||
| Filed 2026-03-31 10:28 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,664
+226 vol $11.79 each |
226 | |
| Filed 2026-03-31 10:25 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,638
+1,012 vol $11.50 each |
||
| Older filings | ||||||
| Filed 2026-03-27 16:45 Tx date 2026-03-26 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+4,354 vol |
4,354 | |
| Filed 2026-03-27 16:41 Tx date 2024-06-17 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-17 14:20 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,638
+1,012 vol $11.50 each |
15,827 | |
| Filed 2025-03-19 13:29 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+5,479 vol |
14,815 | |
| Filed 2025-03-19 13:28 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$726.48
+72 vol $10.09 each |
9,336 | |
| Filed 2025-03-19 13:25 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,346
+204 vol $11.50 each |
9,264 | |
| Filed 2024-10-01 13:51 Tx date 2024-08-26 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+9,060 vol |
9,060 | |
| Filed 2024-10-01 13:49 Tx date 2024-06-17 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-18 14:54 Tx date 2024-06-17 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-18 14:54 Tx date 2024-06-17 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,060 | ||